You've chosen Americas as your location.

To clear your location selection and return to IPS Global, click below.

Return to IPS Global

You've chosen Americas as your location.

Thank you for choosing a location. This will help us show you the information that matters the most to you.

Continue Change Selection
Insights

Annex 1 (2022) – The Brave New World of Regulatory Compliance

After six years in draft form and through various consultations with Industry, the revision to Annex 1 was finally released in August 2022, and will become effective in August 2023. It is the greatest single change to regulatory approach in decades. 

Those following the journey of the draft Annex 1 through to fruition have already identified and largely anticipated the changes to the previous Annex 1. Indeed for many pharmaceutical manufacturers, Annex 1 now aligns closer with the technologies and processes they have already built into their manufacturing facilities over the last few years. 
 

Read the full article on ISPE.org.

Related Experts

Choose Your Location

To customize your experience, select an IPS region or country to view specific information based on your location.

  • Americas
  • United States
  • Canada
  • Brazil
  • All Other Countries

You’ve chosen as your location.

Thank you for choosing a location. This will help us show the information that means to most to you. Continue to the homepage to view featured projects, and happenings specific to your location.

Continue

We use cookies to personalize and enhance your experience on our site. Visit our Privacy Policy to learn more.